Anti Inflammatory Medication May Treat Type 2 Diabetes
                   
medicalnewstoday.com     May 22, 2008            

Researchers at the Joslin Diabetes Center who reported earlier this year that an inexpensive, non-steroidal anti-inflammatory drug called salsalate might prevent type 2 diabetes are now reporting that the drug may also be beneficial in the treatment of the disease. [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

                   

CT: Opiate addiction fueling Norwich drug trade: Rise in heroin use tied to painkillers -...

drugpolicycentral.com     27 mins ago          

Is fueling the drug trade in Norwich. Is fueling the drug trade in Norwich. Is fueling the drug trade in Norwich. Law enforcement officials launched raids in Norwich and Sprague and arrested 22 people who they suspect are...                

comments

                   

Officials investigate doctor in six deaths

drugpolicycentral.com     29 mins ago          

The stories are beginning to emerge as Ventura County prosecutors decide whether to file homicide charges against Bass. (Sun Jul 27 02:04:03 2008 PDT)[$drug_related(100%), $drugwar_propaganda(100%), $propaganda_theme1(100%),...                

comments

                   

Deadly abuse of prescription painkillers skyrockets in Montana

billingsgazette.net     2 hrs ago          

The face of addiction in Montana has a new look: Clean. Middle class. Legal. While gruesome images of meth addicts grab the billboards, the number of people abusing prescription painkillers statewide has skyrocketed, with a...                

comments

                   

COURT BRIEFS

delawareonline.com     3 hrs ago          

Cephalon sues Barr Pharmaceuticals to block sale of generic painkiller Cephalon Inc. sued Barr Pharmaceuticals Inc. this week to prevent it from selling a low-cost copy of the painkiller Fentora in the U.S. Barr, which is being...                

comments